CDEK
← All drugs Report issue

bone marrow derived mononuclear cells

Cell therapyexperimental

Clinical trial activity

29 trials · 38 clinical orgs · 0 marketing orgs

Phase 1
20
Phase 2
20
Phase 3
4
Phase 4
0

Earliest trial started Aug 1, 2003 (NCT00278512)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2004

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Stem CellTissue restoration

    Stem Cell tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • allogenic autologous bone marrow ctl
  • bone marrow derived mononuclear cells
  • bone marrow mononuclear cell
  • bone marrow mononuclear cells
  • bone marrow mononucleated cells
  • cd34+ selected bone marrow mononuclear cells
  • hematopoietic bone marrow

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05665140Phase 2/Phase 3 (Phase 3)Jan 31, 2023Universitaetsklinikum Schleswig-Holstein
NCT04233892Phase 1/Phase 2 (Phase 2)Jan 31, 2020Chinese Academy of Medical Sciences, Nanjing University
NCT03880656Phase 1Jul 31, 2019Oregon Health and Science University, University of Pittsburgh
NCT03943940Phase 1/Phase 2 (Phase 2)Apr 24, 2019Van Hanh General Hospital
NCT03227198Phase 1/Phase 2 (Phase 2)Dec 15, 2018Tabriz Medical University
NCT03948035Phase 3Aug 28, 2018ClinAssess GmbH, Julius-Maximilians University, Wuezburg University Hospital
NCT03484741Phase 1/Phase 2 (Phase 2)Apr 1, 2017University of Science Ho Chi Minh City, Van Hanh General Hospital
NCT03214887Phase 1/Phase 2 (Phase 2)Jan 17, 2017Academia Sinica, Taiwan, National Cheng Kung University, National Taiwan University
NCT02648386Phase 1/Phase 2 (Phase 2)Jan 1, 2016Chinese Academy of Medical Sciences, Nanjing University
NCT02688062Phase 1/Phase 2 (Phase 2)Jan 1, 2016Chinese Academy of Medical Sciences, People's Liberation Army of China
NCT02352077Phase 1Jan 1, 2015Chinese Academy of Medical Sciences, Logistics University of CAPF, People's Liberation Army of China, Soochow University
NCT01958177Phase 1/Phase 2 (Phase 2)Sep 1, 2014Chaitanya Hospital
NCT01876017Phase 1/Phase 2 (Phase 2)Sep 1, 2014Chaitanya Hospital
NCT01908400Phase 1/Phase 2 (Phase 2)Sep 1, 2014Chaitanya Hospital
NCT02237547Phase 1/Phase 2 (Phase 2)Sep 1, 2014Translational Biosciences
NCT02241395Phase 1Aug 1, 2013Neurogen Brain and Spine Institute
NCT00869024Phase 1/Phase 2 (Phase 2)Nov 10, 2011University of Minnesota
NCT01480414Phase 1/Phase 2 (Phase 2)Sep 1, 2010Royan Institute
NCT01302171Phase 2Aug 1, 2010Barts & The London NHS Trust, University of London
NCT01089387Phase 1/Phase 2 (Phase 2)May 1, 2010Institut National de la Santé Et de la Recherche Médicale, France
Showing 20 of 29 trials
Page 1 / 2

Organizations

Research & Development (38)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chinese Academy of Medical SciencesAcademic/Hospital4322015
Chaitanya HospitalAcademic/Hospital3312014
People's Liberation Army of ChinaGovernment3122008
Nanjing UniversityAcademic/Hospital2112016
National Heart, Lung, and Blood Institute (NHLBI)Government2022004
University of MinnesotaAcademic/Hospital2222007
Van Hanh General HospitalAcademic/Hospital2212017
Academia Sinica, TaiwanAcademic/Hospital1112017
Barts & The London NHS TrustAcademic/Hospital1112010
Blood and Marrow Transplant Clinical Trials NetworkAcademic/Hospital1012004
Center for International Blood and Marrow Transplant ResearchGovernment1012004
ClinAssess GmbHFor profit1012018
Columbia UniversityAcademic/Hospital1112007
Duke UniversityAcademic/Hospital1112009
Institut National de la Santé Et de la Recherche Médicale, FranceAcademic/Hospital1112010
Instituto de Molestias CardiovascularesAcademic/Hospital1012009
Julius-Maximilians UniversityAcademic/Hospital1112018
Logistics University of CAPFAcademic/Hospital1012015
Medical College of WisconsinAcademic/Hospital1112004
National Cancer Institute (NCI)Government1012004
38 organizations
Page 1 / 2